{"title":"Adipocyte caspase-1 deficiency promotes white fat beiging via COX7A2L-dependent mitochondrial respiration.","authors":"Yumeng Wang, Jiajie Li, Weijiong He, Furong Zhao, Yunzi Kang, Yewei Cui, Hongxiang Zeng, Ting Zeng, Rui Cheng, Shujin Wang, Linqiang Zhang, Rui Wang, Xueya Zhao, Liuling Xiao, Xi Li","doi":"10.1016/j.metabol.2026.156729","DOIUrl":null,"url":null,"abstract":"<p><p>Beiging of white adipose tissue (WAT) is a promising strategy to enhance energy expenditure and combat obesity, a growing global health burden. Here, we identify a non-canonical role of caspase-1, a cysteine protease, in regulating adipocyte thermogenesis. Caspase-1 expression in adipocytes of inguinal WAT is downregulated upon cold exposure but elevated in obesity. Adipocyte-specific caspase-1 deficiency promotes WAT beiging, increases whole-body energy expenditure, and ameliorates high-fat diet-induced obesity and metabolic dysfunction. Mechanistically, cAMP signaling suppresses Casp1 transcription via C/EBPβ. Proteomic and functional analyses reveal that caspase-1 interacts with and modulates the protein levels of COX7A2L, a subunit of mitochondrial complex IV. Loss of Casp1 stabilizes COX7A2L, thereby enhancing mitochondrial respiration. Moreover, CASP1 expression in human WAT significantly increases with obesity and metabolic dysfunction. Accordingly, we developed a sustained-release delivery system for the caspase-1 inhibitor Ac-YVAD-CHO, which effectively protects against diet-induced obesity and improves glucose tolerance in mice. These findings reveal a previously unrecognized inflammation-independent role of adipocyte-intrinsic caspase-1 in adipose beiging and highlight caspase-1 as a potential therapeutic target for obesity.</p>","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":" ","pages":"156729"},"PeriodicalIF":16.7000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolism: clinical and experimental","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.metabol.2026.156729","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/5 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Beiging of white adipose tissue (WAT) is a promising strategy to enhance energy expenditure and combat obesity, a growing global health burden. Here, we identify a non-canonical role of caspase-1, a cysteine protease, in regulating adipocyte thermogenesis. Caspase-1 expression in adipocytes of inguinal WAT is downregulated upon cold exposure but elevated in obesity. Adipocyte-specific caspase-1 deficiency promotes WAT beiging, increases whole-body energy expenditure, and ameliorates high-fat diet-induced obesity and metabolic dysfunction. Mechanistically, cAMP signaling suppresses Casp1 transcription via C/EBPβ. Proteomic and functional analyses reveal that caspase-1 interacts with and modulates the protein levels of COX7A2L, a subunit of mitochondrial complex IV. Loss of Casp1 stabilizes COX7A2L, thereby enhancing mitochondrial respiration. Moreover, CASP1 expression in human WAT significantly increases with obesity and metabolic dysfunction. Accordingly, we developed a sustained-release delivery system for the caspase-1 inhibitor Ac-YVAD-CHO, which effectively protects against diet-induced obesity and improves glucose tolerance in mice. These findings reveal a previously unrecognized inflammation-independent role of adipocyte-intrinsic caspase-1 in adipose beiging and highlight caspase-1 as a potential therapeutic target for obesity.
期刊介绍:
Metabolism upholds research excellence by disseminating high-quality original research, reviews, editorials, and commentaries covering all facets of human metabolism.
Consideration for publication in Metabolism extends to studies in humans, animal, and cellular models, with a particular emphasis on work demonstrating strong translational potential.
The journal addresses a range of topics, including:
- Energy Expenditure and Obesity
- Metabolic Syndrome, Prediabetes, and Diabetes
- Nutrition, Exercise, and the Environment
- Genetics and Genomics, Proteomics, and Metabolomics
- Carbohydrate, Lipid, and Protein Metabolism
- Endocrinology and Hypertension
- Mineral and Bone Metabolism
- Cardiovascular Diseases and Malignancies
- Inflammation in metabolism and immunometabolism